What Is Asbestos-Related Lung Cancer?
Asbestos-related lung cancer is a malignant tumor that develops inside the lung tissue as a direct result of asbestos exposure. It is the most common asbestos-related cancer, diagnosed more frequently than mesothelioma.
Between 4% and 12% of lung cancers are attributed to occupational asbestos exposure, according to research published by Japan’s Ministry of the Environment, with a separate global burden analysis finding that occupational asbestos exposure accounts for approximately 9.4% of all lung cancer deaths worldwide. Tumors typically take 15 to 35 years to develop after initial exposure.
Certain groups carry a higher risk, including veterans, construction workers, shipyard workers, insulation workers, and anyone who worked in industries where asbestos was heavily used before its regulation.
How Does Asbestos Cause Lung Cancer?
When asbestos fibers are inhaled, they travel deep into the lungs, where they become permanently embedded in the lung tissue. Unlike other particles, the body cannot break down or expel asbestos fibers. Over time, the embedded fibers trigger a cycle of chronic inflammation and cellular damage. This persistent irritation causes scarring of the lung tissue, known as fibrosis, and gradually disrupts normal cell function. The ongoing DNA damage caused by this process can eventually lead to mutations and uncontrolled growth, which is how cancer develops.
The risk follows a dose-response relationship, meaning it increases with both the amount of asbestos inhaled and the duration of exposure. Smoking significantly compounds this risk. Research shows that asbestos exposure alone can make lung cancer more than five times more likely, even in people who have never smoked. When combined with tobacco smoke, the risk increases further, exceeding what either factor would produce independently.
Research shows that people exposed to both asbestos and tobacco smoke face a higher risk of developing lung cancer than those exposed to either factor alone.
Types of Asbestos Lung Cancer
Asbestos exposure can cause two main types of lung cancer, classified by the size and appearance of the cancer cells under a microscope.
- Non-small cell lung cancer (NSCLC) accounts for approximately 80% to 85% of all lung cancer diagnoses and is the more common type seen in asbestos-exposed patients. It tends to grow and spread more slowly than SCLC and includes three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
- Small cell lung cancer (SCLC) accounts for approximately 10% to 15% of diagnoses. It grows and spreads significantly faster than NSCLC and requires early, aggressive treatment to manage effectively.
Symptoms of Asbestos-Related Lung Cancer
Symptoms of asbestos-related lung cancer are identical to those of lung cancer from other causes. They tend to appear in later stages of the disease, which is one reason asbestos-related lung cancer is frequently diagnosed after it has already progressed. Anyone with a known history of asbestos exposure should discuss regular screening with their doctor, even in the absence of symptoms.
Common symptoms include:
- Persistent cough or a change in a chronic cough
- Chest pain or tightness
- Shortness of breath
- Coughing up blood
- Hoarseness or wheezing
- Unexplained weight loss
- Loss of appetite
- Fatigue
- Swelling of the face or neck
- Recurring respiratory infections
How Is Asbestos-Related Lung Cancer Diagnosed?
Diagnosing asbestos-related lung cancer follows the same process as any lung cancer diagnosis, with one important addition: a detailed occupational and exposure history. Informing your doctor about past asbestos exposure is critical, as it directly influences how aggressively they screen and what they look for.
The diagnostic process typically involves:
- Medical and exposure history, including duration and type of asbestos contact
- Imaging, including chest X-rays, CT scans, and PET scans, to identify tumors and assess spread
- Biopsy to collect tissue samples and confirm the presence of cancer cells
- Pathological analysis to determine cancer type and stage
Establishing that a lung cancer diagnosis is attributable to asbestos exposure follows criteria known as the Helsinki Criteria, which recognize causation through either a history of significant occupational, domestic, or environmental asbestos exposure beginning at least 10 years before diagnosis, or pathologic evidence of asbestos exposure such as asbestosis, pleural plaques, or asbestos fibers in tissue analysis.
Treatment Options for Asbestos-Related Lung Cancer
Treatment for asbestos-related lung cancer follows the same protocols as other forms of lung cancer and depends on the cancer type, stage, and the patient’s overall health. Most treatment plans involve a combination of approaches.
- Surgery is the primary option for early-stage disease and aims to remove the tumor and affected lung tissue.
- Chemotherapy is used to kill cancer cells and is commonly used when the cancer has spread beyond the lungs.
- Radiation therapy targets and kills cancer cells or slows tumor growth, and is often used alongside surgery or chemotherapy.
- Immunotherapy helps the body’s immune system identify and attack cancer cells, and is now a standard first-line option for many NSCLC patients.
Clinical trials may offer access to newer treatment approaches for patients who are candidates.
Mesothelioma vs. Asbestos-Related Lung Cancer
Both diseases are caused by asbestos exposure and share a long latency period, but they are distinct diagnoses that develop in different parts of the body and require different treatment approaches.
| Mesothelioma | Asbestos Lung Cancer | |
| Where it forms | Lining surrounding the lungs, abdomen, or heart | Inside the lung tissue itself |
| Cause | Almost exclusively asbestos exposure | Asbestos exposure, often combined with smoking |
| How common | Approximately 2,700 U.S. diagnoses per year | Diagnosed significantly more often than mesothelioma |
| Symptoms | Chest pain, shortness of breath, abdominal swelling | Persistent cough, chest pain, shortness of breath |
| Treatment | Surgery, chemotherapy, immunotherapy | Surgery, chemotherapy, radiation, immunotherapy |
How a Patient Advocate Can Help
A lung cancer diagnosis connected to asbestos exposure brings immediate questions about treatment, finances, and next steps. Navigating those decisions alone is difficult, and you don’t have to.
Speak with a Patient Advocate at no cost and with no obligation. We also offer a free downloadable asbestos lung cancer guide, a detailed resource designed to help patients and families understand their diagnosis, navigate next steps, and access the financial support available to them.